Companies: 10,795·Total market cap: $144.5T
Eli Lilly and Company

Eli Lilly and Company

LLYNYSEHealthcare● Active
$1,131.42
+$6.15(+0.55%)
Market Cap$1.07T
P/E Ratio
52W High$1166.29
52W Low$623.78

Eli Lilly and Company (LLY) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

lly · stock forecast · 45 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 45 Wall Street analysts in the past 3 months

SellBuy

Buy

45 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
33
Hold
9
Sell
3
Strong Sell
0
Total: 45 · Buy rate: 73.3%

12-Month Price Target

High

$1400

Consensus

$1266

+11.9% upside

Low

$1119

Median: $1270 · Last Close: $1131.42

The Eli Lilly and Company (LLY) analyst consensus is Buy, based on ratings from 45 Wall Street analysts over the past 3 months. The average 12-month LLY price target is $1266.17, representing +11.9% upside from the current price of $1131.42.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $1266 (11.9%)

Consensus Target

$1266.17

11.9% upside

High Target

$1400

23.7%

Low Target

$1119

-1.1%

Current Price

$1131.42

as of today

Based on analyst price targets, the LLY stock price prediction for the next 12 months ranges from $1119 to $1400. The consensus LLY price forecast of $1266.17 implies 11.9% upside from the current price of $1131.42.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$1166.253.08%

1-day model range: $1160.36–$1172.14. Peak: $1172.14 (+3.08%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1793+58.5%
2028$2475+118.8%
2029$3087+172.8%
2030$3583+216.7%
2031+249.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)71.7Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · LLY · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1096.36BUY
MA 10$1092.63BUY
MA 20$1046.45BUY
MA 50$973.02BUY
MA 100$993.88BUY
MA 200$947.62BUY
Current $LLY · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1106.75BUY
EMA 10$1087.59BUY
EMA 20$1054.01BUY
EMA 50$1008.15BUY
EMA 100$987.76BUY
EMA 200$951.50BUY
Current $LLY · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
B of A Securities2026-05-26
Maintains
BuyBuy
Barclays2026-05-05
Maintains
OverweightOverweight
Guggenheim2026-05-05
Maintains
BuyBuy
Wolfe Research2026-05-04
Maintains
OutperformOutperform
Cantor Fitzgerald2026-05-01
Maintains
OverweightOverweight
Guggenheim2026-04-22
Maintains
BuyBuy
Morgan Stanley2026-04-10
Maintains
OverweightOverweight
B of A Securities2026-04-02
Maintains
BuyBuy
Guggenheim2026-03-30
Maintains
BuyBuy
HSBC2026-03-17
Downgrade ↓
HoldReduce

Wall Street analysts have recently issued updated ratings on Eli Lilly and Company (LLY) stock. Of the recent 448 rating actions, 48 were upgrades and 38 were downgrades. 45 analysts currently cover LLY.

Analyst Recommendation Trends

Buy ratings45↑ +1
Hold ratings00
Sell ratings00

LLY analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 5 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$84.8B

↓ 23.0% YoY

Revenue Next Year

$98.2B

↑ 15.8% YoY

EPS This Year

$36.58

EPS Next Year

$44.56

↑ 21.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LLY EPS of $36.58 for the current fiscal year, based on estimates from 16 analysts. The LLY revenue forecast is $84.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The LLY stock forecast is supported by two independent data sources: analyst consensus ratings from 45 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LLY price target is $1266.17 (+11.9% upside), with an analyst consensus of Buy.

The LLY short-term stock prediction for tomorrow is $1166.25 (+3.08%). The LLY stock price prediction for 2027 estimates an average of $1793. The LLY stock prediction for 2030 projects a range of $3385–$3781.

Eli Lilly and Company trades on NYSE under the ticker LLY. The LLY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 73% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

LLY forecast · 8 questions

According to 45 Wall Street analysts, the average 12-month LLY price target is $1266.17, with a high forecast of $1400.00 and a low of $1119.00. The median price target is shown in the chart above when available. This implies +11.9% potential upside from the current price of $1131.42.

LLY price targetWhat is LLY price targetLLY analyst price targetLLY 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.